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Abstract 
Background: With the increasing popularity of water‑pipe smoking (WPS), it is critical to comprehend how WPS 
may affect women’s health. The main goal of this study is to identify the potential outcome of WPS on human breast 
cancer progression.
Methods: Two breast cancer cell lines, MCF7 and BT20, were used in this investigation. We explored the outcome of 
WPS on cell morphology and cell invasion using inverted microscope and Biocoat Matrigel invasion chambers. On the 
other hand, Western blot was employed to study the expression patterns of key control genes of cell adhesion and 
invasion.
Results: Our data reveal that WPS induces epithelial–mesenchymal transition (EMT) of MCF7 and BT20 breast cancer 
cell lines; thus, WPS enhances cell invasion ability of both cell lines in comparison with their matched controls. More 
significantly, WPS provokes a down‑ and up‑regulation of E‑cadherin and focal adhesion kinase (FAK), respectively, 
which are important key regulators of cancer progression genes. Finally, our data point out that WPS incites the 
activation of Erk1/Erk2, which could be behind the stimulation of EMT and invasion as well as the deregulation of 
E‑cadherin and FAK expression.
Conclusion: Our data show, for the first time, that WPS initiates EMT and stimulates cell invasion of breast cancer 
cells, which could incite metastatic development in breast cancer patients. Thus, we believe that further studies, both 
in vitro and in vivo, are required to elucidate the pathogenic outcome of WPS on cancer progression of several human 
carcinomas including breast.
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Background
Tobacco smoking, although easily preventable, is con-
sidered a major cause of morbidity and mortality 
worldwide, accounting for 6  million deaths each year 
(World Health Organization). Tobacco smoking today 
has different forms including cigarette, cigar smoking, 
e-cigarettes as well as water pipe. Indeed, water-pipe 
smoking (WPS) is the most common tobacco use in the 
Middle-East region, and its popularity around the globe 
is rapidly increasing to the extent that WPS has been 
described as a global epidemic [1]. Water pipe provides 
a variety of flower-flavored tobacco in addition to vari-
ous spices and fruits with some regional and cultural 
differences [2]. Common misconceptions that consider 
WPS less harmful than cigarettes exist, which have 
been pointed out in several studies [2, 3]. Neverthe-
less, earlier investigations reported the obvious harmful 
effects of WPS on human health, which are compara-
ble, and maybe even worse, than that of cigarette smok-
ing [4–6]. Thus, meta-analysis reports clearly indicate 
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positive associations between WPS and chronic dis-
eases such as lung, esophageal and bladder cancer, 
respiratory illness, low birth weight and periodontal 
diseases [7, 8]. On the other hand, passive smoke from 
WPS can also cause serious risk of respiratory diseases 
as well as other health disorders and possibly cancers in 
exposed nonsmokers [9–11].
To date, it has been well established that cigarette 
smoking can have multiple adverse effects on human 
health including cardiovascular and lung diseases as 
well as several types of cancers such as breast [12–15]. 
For instance, recent investigations have clearly showed 
that both active and passive smokers have a higher risk 
of breast cancer development and mortality related to 
this disease compared to non-smokers [16–18]. On 
the other hand, it has been pointed out that cigarette 
smoking enhances cell invasion and metastatic devel-
opment of different types of cancer by the initiation 
of epithelial–mesenchymal transition (EMT) [19–21], 
which is the hallmark of cancer progression [22]. Thus, 
it is evident that tobacco smoking can play an impor-
tant role in the development and progression of sev-
eral human carcinomas including breast. However, the 
impact of WPS on breast carcinogenesis has not been 
investigated yet. Therefore, in this study, we explored, 
for the first time, the outcome of WPS on breast cancer 
progression. Our data show that WPS can induce EMT 
and stimulate cell invasion of human breast cancer cells 
via the deregulation of several key controller genes of 
cancer invasion and metastasis. Thus, we believe that 
more, in  vitro and in  vivo, investigations are neces-
sary to elucidate the outcome of WPS in breast cancer 
progression.
Materials and methods
Smoking machine protocol and WPS preparation
A standard smoking protocol (Aleppo Method) was used 
as described previously by our group [23]. The water 
pipe was prepared by padding the head with 10 gr of 
brand tobacco mixture known as “Two Apples”, covering 
it with aluminum foil and perforating the foil to allow 
air passage. A charcoal, “Three Kings” brand quick-light 
briquette, was ignited and placed on top of the head at 
the beginning of the smoking session. Water in the water 
bowl was changed at the beginning of every smoking 
session. The condensate (smoking) was collected using 
regular laboratory filter paper. Filters were dried and 
weighed before and after collecting smoke and drying. 
Afterwards, smoked-filters were solved in PBS or RPMI 
medium (Qiagen, Toronto, ON) with final concertation 
of 20  mg/ml of smoking particles; then PBS and RPMI 
solutions were filtered using 0.45 μm (Costar, USA).
Cell lines
Two human breast cancer cell lines, MCF7 and BT20, 
were used in our investigation. Cell lines were obtained 
from the American Type Culture Collection (Rock-
ville, MD, USA) and maintained in a humidified atmos-
phere of 5%  CO2 in air at 37 °C. The cells were routinely 
cultured in RPMI 1640 supplemented with 10% fetal 
bovine serum (Life Technologies, Inc., ON, Canada), 
2  mM  l-glutamine, and 100  µg/ml penicillin–strepto-
mycin. Cancer cells were treated with 100 and 200 μg/
ml PBS or RPMI solution of WPS; in parallel, control 
cells were exposed to the same volume of PBS or RPMI 
serum free.
Invasion assay
Cell invasion was assayed in 24-well Biocoat Matrigel 
invasion chambers (8 µm; Becton–Dickinson, ON, Can-
ada) according to the manufacturer’s protocol. Briefly, 
cells were incubated with 200  μg of WPS solution, and 
their control (5 × 104) were plated without WPS solution. 
Both groups were seeded in the top chamber of Biocoat 
Matrigel wells. The bottom chamber contained RPMI 
medium with 10% serum. After 24-h incubation non-
invasive cells were removed with a cotton swab while 
cells that migrated through the membrane and stuck to 
the lower surface of the membrane were fixed with meth-
anol and stained with 0.5% crystal violet. For quantifica-
tion, cells were counted under a microscope as previously 
illustrated by our group [24].
Clonogenic cell assay
Five hundred cells of MCF7 and BT20 were plated in 
6-well plates in duplicates. Cells were washed and fresh 
medium was added in the presence or absence of 200 μg 
of WPS solution. The experiment was discontinued when 
the clones reached 50 cells/clone in each well (~ 7 days), 
then colonies were fixed and stained with 1.5 ml of 6.0% 
glutaraldehyde and 0.5% crystal violet. Next, colonies 
were counted using GelCount (Oxford optronix, UK). 
The colony fraction (CF) of cells was calculated as previ-
ously described [25].
Western blot analysis
MCF7 and BT20 cells were treated with 200  μg/ml of 
WPS solution in PBS or serum free RPMI for 3  days, 
as described above. Afterwards, western blot was per-
formed as previously described by our group [26]. Briefly, 
30 μg of protein from each sample was used in this assay. 
Protein samples were then blotted on a nitrocellulose 
membrane and detected with anti-E-cadherin and FAK 
monoclonal antibodies (mAbs) (Bio/Can Scientific), and 
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anti-Erk1/Erk2 phosphotyrosine mAb (Upstate Biotech-
nology, NY, USA).
Statistical analysis
Data analyses were performed using SPSS  64-bit  ver-
sion 23 (IBM, NY, USA). Normality of data was con-
firmed  using Shapiro–Wilk test and histograms. Data 
were  analyzed using T-test to determine statistical sig-
nificance. All tests were two-tailed and results were con-
sidered statistically significant if P-values were less than 
0.05.
Results
In order to study the effect of WPS on human breast car-
cinogenesis, we examined the outcome of WPS on two 
non- invasive breast cancer cell lines, MCF7 and BT20. 
Our data revealed that treatment of human breast can-
cer cells with 100–200 μg/ml of WPS solution for 3 and 
8  days slightly deregulates cell cycle progression and 
increases colony formation, respectively, of MCF7 and 
BT20 cell lines in comparison with untreated cells (data 
not shown; Fig.  1). On the other hand, we found that 
WPS-exposure induces EMT, where both MCF7 and 
BT20 cells display a more mesenchymal phenotype, 
and form disorganized multilayered cells in compari-
son with their matched unexposed controls (Fig. 2). The 
cells become more elongated in appearance, and show a 
decrease in cell–cell contact compared with untreated 
ones. 
To evaluate the role of WPS on cell invasion and migra-
tion abilities of human breast cancer cells, matrigel inva-
sion and wound-healing assays were performed. In these 
experiments, MCF7 and BT20 cells were treated for 48 h 
with 200  μg/ml of WPS solution. We found that WPS 
stimulates cell invasion and migration abilities of both 
cell lines in comparison with their unexposed controls 
(Fig.  3). Next, we examined the differential expression 
patterns of E-cadherin and FAK by Western blot analy-
sis of MCF7 and BT20 cells that were either exposed to 
200  μg/ml of WPS for approximately 48  h or left unex-
posed. The results of this analysis were consistently cor-
related with cell phenotype as well as the invasion and 
migration ability of both cell lines. Following WPS expo-
sure, the expression of E-cadherin is down-regulated 
in comparison with unexposed cells, in contrast, FAK 
expression is up-regulated in MCF7 and BT20 control 
cells in comparison with WPS-exposed ones, which is 
consistent with EMT progression (dedifferentiation to 
mesenchymal phenotype) (Figs. 4, 5). In contrast, unex-
posed cells show a higher and a lower expression of 
E-cadherin and FAK, respectively, which is also coherent 
with EMT progression that enhances cell migration and 
invasion abilities.
Regarding the mechanisms of WPS on the initiation of 
EMT and therefore cell invasion in human breast can-
cer cells, we assumed that the main mechanism behind 
these events could be Erk1/Erk2 signaling pathways, 
since it has been reported that tobacco smoking can pro-
voke EMT via Erk1/Erk2 pathways [19, 21]. Thus, Erk1/
Erk2 activation was assessed in MCF7 and BT20 cell lines 
exposed to WPS in comparison with their matched con-
trol cells. We found that Erk1/Erk2 is phosphorylated 
under the effect of WPS, in both cell lines in compari-
son with their control (Figs. 4, 5). Meanwhile, we noted 
that there is no significant difference in total Erk1/Erk2 
expression between WPS exposed and control cells (data 
not shown).
Discussion
In this investigation, we explored for the first time the 
outcome of WPS on breast carcinogenesis. Indeed, the 
effect of WPS on breast cancer initiation and/or progres-
sion has not been explored yet. Our study revealed that 
WPS can initiate the EMT event in human breast can-
cer cells, which is the hallmark of cancer progression 
and metastasis [22]. Moreover, our data show clearly 
that WPS stimulate cell invasion of human breast cancer 
cells. While, numerous recent investigations have demon-
strated a strong association between tobacco smoking and 
breast cancer development and progression in addition 
to recurrence and mortality [15, 27–29]. Also, it has been 
revealed that cigarette smoking can enhance EMT of sev-
eral human carcinoma cells including breast [19, 30–33]. 
Additionally, earlier studies showed that cigarette smok-
ing could increase breast cancer recurrence by 37%, and 
therefore increase the overall mortality by 54% compared 
Fig. 1 Effects of water‑pipe smoking (WPS) on colony formation 
in human breast cancer cell lines. WPS slightly enhances colony 
formation of MCF7 and BT20 cell lines in comparison with their 
control cells. Clonogenic cell assay and WPS exposure were 
performed as described in “Materials and methods” section
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with nonsmoking patients [16]. Thus, it is evident today 
that tobacco smoking is an important etiological factor in 
the development of several types of human cancers induc-
ing lung, oral as well as breast [34]. While, it is important 
to emphasize that WPS contains the same toxins as ciga-
rette, including high levels of nicotine, heavy metals, par-
ticulate matter, and numerous carcinogens, it also adds 
the adverse effect of charcoal used to heat the tobacco [4–
6]. Therefore, WPS can increase health risks by producing 
high levels of pollutants, such as carbon monoxide, metals 
and cancer-causing chemicals [35]. Thus, it is evident that 
WPS can be more detrimental on the development and 
progression of human cancers as well as cancer-related 
deaths in comparison with cigarette smoking. Indeed, our 
study points out that WPS can initiate EMT and there-
fore enhance cancer invasion ability of two non-invasive 
breast cancer cell lines. This effect was accompanied with 
a downregulation of E-cadherin, which is considered an 
important tumor invasion suppressor. Meanwhile, our 
data reveal that WPS can enhance the expression pattern 
of FAK gene; as several investigations reported that FAK 
Fig. 2 WPS stimulates epithelial–mesenchymal transition (EMT) of breast cancer cell lines, MCF7 and BT20. We note that treatment for 3 days with 
200 μg/ml of WPS solution induces morphological changes from “epithelial‑like” (control) cells into “fibroblast‑like” (mesenchymal) phenotype, which 
is known as EMT
Fig. 3 Effect of WPS on cell invasion of human breast cancer cells. 
The results from matrigel invasion assay indicate that WPS enhances 
cell invasion ability of MCF7 and BT20 cell lines by approximately 
35% in comparison with their control cells. The histograms show 
mean ± SD (P < 0.002 and 0.001, respectively; t‑test was used and is 
considered significant with P < 0.05). The cancer cells were treated 
with 200 μg of WPS solution for 2 days as described in “Materials and 
methods” section
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is an important key controller gene of cell invasion and 
metastasis in several types of human carcinomas includ-
ing breast. Thus, our data concur that cigarette smoking 
can enhance cancer progression via the initiation of EMT, 
which is accompanied by the deregulation of E-cadherin, 
and FAK, as it was clearly demonstrated by several inves-
tigations [36–40]. On the other hand, we have recently 
reported that WPS induces an overexpression of cad-
herin-6 (CDH6) type 2 gene during embryogenesis [23], 
which is also involved in the normal development and 
cancer progression via the initiation of EMT [41–43]. 
Consequently, we assume that WPS can deregulate the 
expression pattern of CDH6 type 2 gene in human cancer 
cells. Taken together, we believe that WPS exposure could 
have a dramatic effect on the progression of several types 
of human cancers, including breast, and therefore, cancer 
mortality.
More significantly, we herein report that WPS acti-
vate Erk1/Erk2, which could be the main pathway behind 
inducing EMT and cell invasion leading to the deregulation 
of E-cadherin and FAK genes in human breast cancer cells. 
Herein, it is important to highlight that WPS did not sig-
nificantly affect the total expression of Erk1/Erk2. Indeed, 
these data are consistent with previous works regarding 
cigarette smoking in relation with EMT and Erk1/Erk2 
activation, as well as E-cadherin deregulation in various 
types of human cancer cells including breast [19, 21, 44–
46]. Thus, the present study show that Erk1/Erk2 activation 
is one of the pathways via which WPS can enhance cancer 
progression and initiate metastasis.
Conclusions
In conclusion, we herein demonstrate for the first 
time that WPS can enhance cancer invasion ability of 
human breast cancer via the initiation of EMT, which 
is an important event in cancer progression. In parallel, 
E-cadherin and FAK genes are major targets of WPS in 
human breast cancer. Finally, our study reveals that this 
effect can occur via the activation of Erk1/Erk2 path-
ways. Therefore, it provides evidence that WPS can play 
a critical role in the progression of human breast cancer. 
Fig. 4 Western blot analysis of E‑cadherin, FAK and p‑Erk1/Erk2 in 
MCF7 and BT20 cell lines under the effect of WPS. We notice that 
WPS decreases/increases the expression patterns of E‑cadherin and 
FAK, respectively, in both cell lines in comparison with control cells; 
meanwhile, WPS stimulates Erk1/Erk2 phosphorylation in these two 
cell lines. GAPDH was used as a control. Cells were treated with WPS 
solution as explained in “Materials and methods” section as well as 
“Results” section
Fig. 5 Quantification of the western blot analysis of E‑cadherin, FAK 
and Erk1/Erk2 phosphorylation as well as GAPDH in MCF7 and BT20 
exposed to WPS and unexposed (control) cells. This analysis confirms 
the downregulation of E‑cadherin in both cell lines; in parallel, WPS 
enhances FAK expression and Erk1/Erk2 phosphorylation in the two 
cell lines in comparison with their control cells. The quantification of 
both data by ImageJ 64‑bit version 1.50b program
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However, further studies are required to elucidate the 
pathogenic effects of WPS on the development and pro-
gression of human carcinomas including breast.
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